Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Introduced
Feb 12, 2025
Last Action
Apr 30, 2025
Session
RI 2025
Sponsors
7 primary · 0 co
04/30/2025 Committee recommended measure be held for further study
04/25/2025 Scheduled for hearing and/or consideration (04/30/2025)
02/12/2025 Introduced, referred to House Finance